Calithera Biosciences

About:

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

Website: http://www.calithera.com

Top Investors: U.S. Venture Partners, Longwood Fund, Adage Capital Management, Morgenthaler Ventures, Advanced Technology Ventures

Description:

Calithera Biosciences is a development-stage pharmaceutical company committed to discovering and developing novel small molecule therapeutics for the treatment of cancer. They are applying Their scientific expertise to build a pipeline of unique anti- cancer drugs that selectively target metabolic and apoptotic pathways critical to tumor growth and survival.

Total Funding Amount:

$341M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2010-06-01

Contact Email:

info(AT)Calithera.com

Founders:

Susan M. Molineaux

Number of Employees:

1-10

Last Funding Date:

2022-03-30

IPO Status:

Public

© 2025 bioDAO.ai